BMC Nephrology invites submissions to our Collection on Personalized approaches to managing hypertension in kidney patients.

Hypertension is a common comorbidity in kidney patients, contributing to the progression of renal disease and increasing the risk of cardiovascular events. Personalized approaches to managing hypertension in this population have gained attention due to the variability in treatment responses and the need to optimize patient outcomes. This Collection gathers research exploring personalized and precision medicine strategies for the regulation of blood pressure in kidney patients, addressing the pathophysiology of hypertension in the context of renal disease and considering acute and chronic kidney injury.

Advancing our collective understanding in this area is crucial for improving the management of hypertension in kidney patients, as it may lead to tailored treatment approaches that consider individual patient characteristics, such as renal function, genetic factors, and comorbidities. Recent advances have highlighted the potential of personalized treatment strategies, including the use of novel antihypertensive agents, individualized dietary interventions, and the integration of digital health technologies for remote monitoring and management of blood pressure in kidney patients.

Looking ahead, continued research in this area holds the potential for the development of innovative biomarker-based approaches for predicting treatment responses, the identification of novel therapeutic targets specific to renal hypertension, and the integration of artificial intelligence and machine learning algorithms for personalized risk prediction and treatment optimization in kidney patients with hypertension.

Topics of interest include, but are not limited to:

Personalized medicine approaches for hypertension in kidney patients

Pathophysiology of hypertension in renal disease

Long-term regulation of blood pressure in kidney patients

Precision medicine strategies for chronic kidney disease and hypertension

Role of gut microbiota in the management of hypertension in kidney patients

Impact of socioeconomic factors on personalized hypertension management in kidney patients

Novel biomarkers for predicting treatment responses in hypertensive kidney patients

Integrative omics approaches for understanding individualized responses to antihypertensive therapies in kidney patients

The influence of environmental factors on personalized hypertension management in kidney patients

This Collection supports and amplifies research related to SDG 3: Good Health and Wellbeing.

All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer-review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.

BMC Nephrology is calling for submissions to our Collection on Biomarkers in kidney disease diagnosis.

Kidney disease remains a pressing global health issue, affecting millions and often leading to significant morbidity and mortality. The identification of reliable biomarkers has emerged as a promising avenue for enhancing the diagnosis and management of kidney diseases. Biomarkers can provide critical insights into the pathophysiology of renal conditions, facilitate early detection, and help tailor treatment strategies to individual patients. With the advent of advanced technologies in molecular biology and genomics, there is a growing interest in understanding how specific biomarkers can improve clinical outcomes in kidney disease.

The significance of advancing biomarker research in kidney disease diagnosis is underscored by recent breakthroughs in the identification of novel biomarkers that improve accuracy and timeliness in detection. These advancements are crucial for the early intervention and management of chronic kidney disease (CKD) and acute kidney injury (AKI). As research continues to evolve, integrating biomarkers into clinical practice can revolutionize the way kidney diseases are diagnosed, monitored, and treated. Furthermore, innovative biomarker applications may allow for better stratification of risk in populations at high risk for kidney disease, paving the way for proactive health management strategies.

Topics of interest for this Collection include, but are not limited to:

Novel biomarkers for kidney disease diagnosis

Early detection methods in kidney pathology

Clinical applications of renal biomarkers

Biomarkers and chronic kidney disease management

This Collection supports and amplifies research related to SDG 3 (Good Health and Well-being) and SDG 9 (Industry, Innovation, and Infrastructure).

All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.